Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
MedMen Enterprises Inc. operates in the cannabis sector, focusing on the cultivation, production, and retail of cannabis products across several states in the U.S., notably California and Nevada. The company has faced significant operational challenges, leading to a substantial decline in market capitalization and profitability metrics, which has raised concerns among investors.
MedMen generates revenue primarily through its retail operations, leveraging its brand presence in key markets to drive sales. The company has a competitive advantage through its established retail locations and a strong brand identity in the cannabis space, although operational inefficiencies and high debt levels have hindered profitability.
Changes in state-level cannabis regulations, particularly in California and Nevada
Consumer demand trends for cannabis products, especially in recreational markets
Operational efficiency improvements and cost management initiatives
Debt restructuring efforts and liquidity management
Regulatory changes that could impact cannabis legality and market access
Market saturation in key states leading to increased competition
Emergence of new competitors with innovative products or lower pricing
Potential market share loss to larger, more established cannabis companies
High debt levels leading to liquidity constraints
Negative operating cash flow impacting financial stability
moderate - The cannabis industry is somewhat insulated from economic downturns due to the nature of its products, but consumer spending patterns can still impact sales.
High interest rates can increase borrowing costs for MedMen, which has a high debt-to-equity ratio, potentially impacting its ability to finance operations and expansion.
high - The company’s significant debt levels and negative cash flow make it sensitive to credit market conditions and refinancing risks.
value - Investors may be looking for turnaround opportunities given the current low valuation and potential for recovery.
high - The stock has exhibited extreme volatility, with a 1-year return of -99.5%, indicating high risk.
